AKT1 and familial pancreatic carcinoma: From reviewing previous studies, miR-29b-2-5p is reported to target CBI-b to inhibit the proliferation of pancreatic cancer cells [25], and miR-101-3p could hinder the growth and metastasis of NSCLC through attenuating MALAT-1 mediated PI3K/AKT signal pathway [26].